ISUOG 2025 – Ultrasound unveiled : Insights in gynecologic oncology

This ISUOG 2025 session, presented by Prof. Valentina Chiappa, outlines the role of gynecologic oncology ultrasound in assessing and staging gynecologic malignancies. The presentation focuses on how standardized ultrasound evaluation can support clinical decision-making across ovarian, endometrial, cervical, and tubal cancers.

Ovarian mass assessment is a central topic, with emphasis on evaluating malignancy risk using lesion morphology, vascular patterns, and tumor heterogeneity. The session discusses the use of validated tools, including IOTA terminology, Simple Rules, and the ADNEX model, to support structured risk stratification and diagnostic consistency.

The webinar also addresses ultrasound-based evaluation of disease spread in ovarian cancer. Assessment of peritoneal involvement, lymph node status, and features associated with tumor non-resectability is reviewed in the context of preoperative planning.

Endometrial cancer assessment is presented with a focus on qualitative evaluation beyond endometrial thickness alone. The session highlights identification of focal lesions, use of sonohysterography, and assessment of myometrial and cervical stromal infiltration to support tumor staging.

Cervical cancer staging is also covered, with ultrasound discussed as an alternative to MRI in selected clinical settings. Evaluation of tumor size, vascularity, parametrial involvement, and adjacent organ infiltration is demonstrated using two-dimensional, Doppler, and three-dimensional ultrasound techniques.

Overall, the session highlights how gynecologic oncology ultrasound supports structured assessment and staging across multiple gynecologic cancer types.

Gynecology, New, Prof. Valentina Chiappa, Associated member, Expert insights, IOTA-ADNEX, IOTA-SRrisk, Adnexal masses, Endometrial lesions, Malignancy, Myometrial lesions, Tumor

ㆍ The contents should not be recorded or redistributed without the consent of the speakers and Samsung.
ㆍ The products, features, and options presented may not be approved, cleared, or commercially available in all jurisdictions. Please contact your local representative for specific product availability in your region.
ㆍ This content is intended for healthcare professionals only. The information presented is for educational purposes and should not be considered medical advice.
ㆍ The clinical results and patient outcomes presented may not be typical and can vary depending on multiple factors including patient condition, treatment technique, and healthcare setting.
ㆍ While we strive to provide accurate and up-to-date information, Samsung makes no warranties regarding the completeness, reliability, or accuracy of the content presented.

Gynecology, New, Prof. Valentina Chiappa, Associated member, Expert insights, IOTA-ADNEX, IOTA-SRrisk, HERA W10 Elite, HERA W10 Elite, HERA Z20, HERA Z20, Adnexal masses, Endometrial lesions, Malignancy, Myometrial lesions, Tumor
Saved

Share

Prof. Valentina Chiappa

Expert insights

Associated member

Applications
Gynecology

Products & Solutions

HERA W10 Elite HERA Z20

Features

IOTA-ADNEX IOTA-SRrisk
Back to list

What are you looking for?

Sign in Required!

Please sign in or sign up to access member-only content.

Update Your Profile

Complete your profile now to ensure uninterrupted, secure access to theSUITE.

Enter your Serial Number

Access various content with simple product registration.

Registration unavailable

Sorry, we can not verify your serial number.
Please use a correct serial number.

Product Registered!

Your product has been successfully registered!

Done
Logout Check Icon
You Successfully log out!
Thank you for visiting theSUITE.
Can not Access

You are already signed in

Cannot sign in

Please enter your email address and password correctly